Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.6.5.4 - signal-recognition-particle GTPase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abortion, Spontaneous
Maternal serum levels of interferon-gamma and interleukin-2 soluble receptor-alpha predict the outcome of early IVF pregnancies.
Adenomatous Polyposis Coli
Identification and characterization of the familial adenomatous polyposis coli gene.
Adenoviridae Infections
Monomeric scAlu and nascent dimeric Alu RNAs induced by adenovirus are assembled into SRP9/14-containing RNPs in HeLa cells.
Colitis
Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa.
Naked gene therapy of hepatocyte growth factor for dextran sulfate sodium-induced colitis in mice.
Colorectal Neoplasms
The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation.
Congenital Bone Marrow Failure Syndromes
Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features.
Connective Tissue Diseases
Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies.
Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.
Treatment and outcomes in necrotising autoimmune myopathy: An Australian perspective.
Cryptogenic Organizing Pneumonia
Signal recognition particle (SRP) positive myositis in a patient with cryptogenic organizing pneumonia (COP).
Dehydration
Cloning and characterization of the goadsporin biosynthetic gene cluster from Streptomyces sp. TP-A0584.
Dermatomyositis
The 72-kDa component of signal recognition particle is cleaved during apoptosis.
DiGeorge Syndrome
Severe Congenital Neutropenia associated with SRP54 mutation in 22q11.2 Deletion Syndrome: Hematopoietic Stem Cell Transplantation Results in Correction of Neutropenia with Adequate Immune Reconstitution.
Gingival Overgrowth
Signal recognition particle receptor (SRPR) is downregulated in a rat model of cyclosporin A-induced gingival overgrowth.
Hepatitis C
Automated RNA tertiary structure prediction from secondary structure and low-resolution restraints.
Hypercholesterolemia
Inhibition of protein translocation across the endoplasmic reticulum membrane by sterols.
Infections
Cellular microRNA miR-10a-5p inhibits replication of porcine reproductive and respiratory syndrome virus by targeting the host factor signal recognition particle 14.
Mechanism of down-regulation of RNA polymerase III-transcribed non-coding RNA genes in macrophages by Leishmania.
SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
What is in the Myopathy Literature?
Kidney Failure, Chronic
Serum concentration of IL-2, IL-6, TNF-alpha and their soluble receptors in children on maintenance hemodialysis.
Latent Infection
The RNA-Binding Proteins SRP14 and HMGB3 Control HIV-1 Tat mRNA Processing and Translation During HIV-1 Latency.
Leukemia
Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors.
Leukemia, Myeloid, Acute
Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia.
Lupus Erythematosus, Systemic
Autoantibodies in the diagnosis of systemic rheumatic diseases.
The 72-kDa component of signal recognition particle is cleaved during apoptosis.
Lupus Nephritis
Immune-mediated necrotizing myopathy, associated with antibodies to signal recognition particle, together with lupus nephritis: case presentation and management.
Lymphopenia
Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy.
Muscular Diseases
A pediatric patient with myopathy associated with antibodies to a signal recognition particle.
Anti-signal recognition particle antibody in patients without inflammatory myopathy: a survey of 6180 patients with connective tissue diseases.
Anti-signal recognition particle myopathy in the first decade of life.
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Complement-mediated muscle cell lysis: A possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM).
Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature.
Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy.
Immune-mediated necrotising myopathy associated with antibodies to the signal recognition particle treated with a combination of rituximab and cyclophosphamide.
Immune-mediated necrotizing myopathy associated with antibodies to the signal recognition particle: A rare cause of hyperCKaemia.
Immune-mediated necrotizing myopathy, associated with antibodies to signal recognition particle, together with lupus nephritis: case presentation and management.
Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle.
Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle.
Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).
Myopathy Associated With Antibodies to Signal Recognition Particle: Disease Progression and Neurological Outcome.
Myopathy with antibodies to the signal recognition particle: clinical and pathological features.
Myositis autoantibodies.
Necrotizing myopathies: beyond statins.
Necrotizing myopathy: clinicoserologic associations.
Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series.
Treatment experience of Taiwanese patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy.
What is in the Myopathy Literature?
[A case of an anti-SRP myopathy with enlargement of the thymus].
[A case of chronic myopathy associated with an antibody to signal recognition particle (SRP) following long-term asymptomatic hypercreatinekinasemia].
[Acquired necrotizing myopathies.]
[Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective].
[Histological and molecular alterations in inflammatory myopathies].
Myositis
Anti-signal recognition particle antibody in patients without inflammatory myopathy: a survey of 6180 patients with connective tissue diseases.
Autoantibodies in polymyositis and dermatomyositis.
Cutting Edge Issues in Polymyositis.
Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature.
Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle.
Myopathy with antibodies to the signal recognition particle: clinical and pathological features.
Myositis specific autoantibodies.
Necrotizing myopathy: clinicoserologic associations.
Signal recognition particle (SRP) positive myositis in a patient with cryptogenic organizing pneumonia (COP).
Spectrum of immune-mediated necrotizing myopathies and their treatments.
Treatment experience of Taiwanese patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy.
What is in the Myopathy Literature?
What's in the Literature?
[Autoantibodies specifically detected in patients with polymyositis/dermatomyositis]
[Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective].
[Diagnostic significance of scleroderma and myositis-associated autoantibodies]
[Histological and molecular alterations in inflammatory myopathies].
Myositis, Inclusion Body
What is in the Myopathy Literature?
Neoplasms
Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.
Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.
Genomic selection of reference genes for real-time PCR in human myocardium.
Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia.
Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry.
The moving parts of the nucleolus.
The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation.
Treatment and outcomes in necrotising autoimmune myopathy: An Australian perspective.
[Detection of gene expression alteration of myeloma cells treated with arsenic trioxide]
Neutropenia
A Filipino infant with severe neutropenia owing to SRP54 mutations was successfully treated with ethnically mismatched cord blood transplantation from a Japanese cord blood bank.
Cellular Traffic Jam and Disease Due to Mutations in SRP54.
Congenital neutropenia with variable clinical presentation in novel mutation of the SRP54 gene.
Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features.
Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.
Severe Congenital Neutropenia associated with SRP54 mutation in 22q11.2 Deletion Syndrome: Hematopoietic Stem Cell Transplantation Results in Correction of Neutropenia with Adequate Immune Reconstitution.
SRP54 and a need for a new neutropenia nosology.
SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing.
Structural and Functional Impact of SRP54 Mutations Causing Severe Congenital Neutropenia.
Three patients with glucose-6 phosphatase catalytic subunit 3 deficiency.
Pneumonia
Signal recognition particle (SRP) positive myositis in a patient with cryptogenic organizing pneumonia (COP).
Polymyositis
Antibody to signal recognition particle in polymyositis.
Autoantibody to signal recognition particle in African American girls with juvenile polymyositis.
Coexistence of anti-Jo1 and anti-signal recognition particle antibodies in a polymyositis patient.
[Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective].
Porcine Reproductive and Respiratory Syndrome
Cellular microRNA miR-10a-5p inhibits replication of porcine reproductive and respiratory syndrome virus by targeting the host factor signal recognition particle 14.
Scleroderma, Systemic
Autoantibodies in the diagnosis of systemic rheumatic diseases.
Shwachman-Diamond Syndrome
SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing.
Structural and Functional Impact of SRP54 Mutations Causing Severe Congenital Neutropenia.
Whole exome sequencing discloses heterozygous variants in the DNAJC21 and EFL1 genes but not in SRP54 in 6 out of 16 patients with Shwachman-Diamond Syndrome carrying biallelic SBDS mutations.
signal-recognition-particle gtpase deficiency
SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing.
Spina Bifida Cystica
Proteomic analysis of amniotic fluid of pregnant rats with spina bifida aperta.
Tuberculosis
Characterization of FtsY, its interaction with Ffh, and proteomic identification of their potential substrates in Mycobacterium tuberculosis.
Essential biochemical, biophysical and computational inputs on efficient functioning of Mycobacterium tuberculosis H37Rv FtsY.